According to the Enterprise Research App, recently, Guangxi Andike Pharmaceutical Co., Ltd. was established. The legal representative is Liu Lin, with a registered capital of 10 million yuan. The scope of business includes pharmaceutical production; third-class medical device management; drug retail; pharmaceutical wholesale; drug import and export. Enterprise investigation and equity penetration shows that the company is wholly owned indirectly by Dongcheng Pharmaceutical.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.